Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacogenomic Study to Predict Neurotoxicity of Oxaliplatin

This study has been completed.
Information provided by:
Samsung Medical Center Identifier:
First received: September 3, 2009
Last updated: April 15, 2010
Last verified: April 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)